Sign in

    Zhiking Zhang

    Research Analyst at CICC

    Zhiking Zhang is an analyst at China International Capital Corporation (CICC), specializing in equity research with a focus on sectors related to healthcare and pharmaceuticals. He covers publicly traded companies such as HUTCHMED and provides regularly published research and investment recommendations, although detailed performance rankings and quantitative metrics are not publicly available. Zhang began his professional career with CICC, and while details of any prior roles or a complete timeline are not documented, he has established his expertise within the firm. Information regarding professional credentials, securities licenses, or formal industry recognitions is not publicly listed.

    Zhiking Zhang's questions to iQIYI (IQ) leadership

    Zhiking Zhang's questions to iQIYI (IQ) leadership • Q2 2025

    Question

    Zhiking Zhang from CICC asked for an overview of content performance during the summer season and inquired about the company's future content strategy in light of the new regulations.

    Answer

    CEO Lu Gong noted the new policies will foster innovation. Chief Content Officer Xiaobui Wang detailed the summer's success, highlighting three original dramas that surpassed a 10,000 popularity index score. He outlined a future strategy focused on premium productions, leveraging drama theaters for key genres, and creating innovative content for long-form dramas, micro-dramas, films, and variety shows.

    Ask Fintool Equity Research AI